SEC Form 3 · accession 0001209191-15-029798
Ignyta, Inc. · RXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Mar 17, 2015
Accepted (ET)
Mar 27, 2015 · 2:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 3,000,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Cephalon, Inc. is an indirect wholly owned subsidiary of Teva Pharmaceutical Industries Limited